Distribution of 4-hydroxynonenal-protein conjugates as a marker of lipid peroxidation and parameter of malignancy in astrocytic and ependymal tumors of the brain

Tumori

Volumn 95, Issue 6, 2009, Pages 762-768

  Juric Sekhar, Gordana ^a   Zarkovic, Kamelija ^a   Waeg, Georg ^b   Cipak, Ana ^c   Zarkovic, Neven ^c  

^a KBC Zagreb   (Croatia)

^b UNIVERSITY OF GRAZ   (Austria)

^c RUDER BO KOVI INSTITUTE   (Croatia)

Author keywords

4 hydroxynonenal; Angiogenesis; Astrocytomas; Ependymomas

Indexed keywords

4 HYDROXYNONENAL;

ANGIOGENESIS; APOPTOSIS; ARTICLE; ASTROCYTOMA; BLOOD VESSEL WALL; CANCER GRADING; CONTROLLED STUDY; ENDOTHELIUM; EPENDYMOMA; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MICROVASCULATURE; MITOSIS; NECROSIS; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TUMOR CELL;

EID: 76349092912     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160909500620     Document Type: Article

References (43)

1. Chung FL, Nath RG, Ocando J, Nishikawa A, Zhang L: Deoxyguanosine adducts of t-4-hydroxy-2-nonenal are endogenous DNA lesions in rodents and humans: detection and potential sources. Cancer Res, 60: 1507-1511, 2000.
2. Hu W, Feng Z, Eveleigh J, Iyer F, Pan J, Amin S, Chung FL, Tang MS: The major lipid peroxidation product, trans-4-hydroxy-2-nonenal, preferentially forms DNA adducts at codon 249 of human p53 gene, a unique mutational hotspot in hepatocellular carcinoma. Carcinogenesis, 23: 1781-1789, 2002.
3. Wacker M, Schuler D, Wanek P, Eder E: Development of a (32)P-postlabeling method for the detection of 1,N(2)-propanodeoxyguanosine adducts of trans-4-hydroxy-2-nonenal in vivo. Development of a (32)P-postlabeling method for the detection of 1,N(2)-propanodeoxyguanosine adducts of trans-4-hydroxy-2-nonenal in vivo. Chem Res Toxicol, 60: 1165-1173, 2000.
4. Sovic A, Borovic S, Loncaric I, Kreuzer T, Zarkovic K, Vukovic T, Waeg G, Hrascan R, Wintersteiger R, Klinger R, Zurak N, Schaur RJ, Zarkovic N: The carcinostatic and proapoptotic potential of 4-Hydroxynonenal in HeLa cells is associated with its conjugation to cellular proteins. Anticancer Res, 21: 1997-2004, 2001.
5. Siddiqui MA, Singh G, Kashyap MP, Khanna VK, Yadav S, Chandra D, Pant AB: Influence of cytotoxic doses of 4-hydroxynonenal on selected neurotrasmitter receptors in PC-12 cells. Toxicol in Vitro, 22: 1681-1688, 2008.
6. Biasi F, Tessitore L, Zanetti D, Citrin JC, Zingaro B, Chiarpotto E, Zarkovic N, Serviddio G, Poli G: Associated changes of lipid peroxidation and transforming growth factor beta1 levels in human colon cancer during tumour progression. Gut, 50: 361-367, 2002.
7. Kreuzer T, Grube R, Zarkovic N, Schaur RJ: 4-Hydroxynonenal modifies the effects of serum growth factors on the expression of the c-fos proto-oncogene and the proliferation of HeLa carcinoma cells. Free Radic Biol Med, 25: 42-49, 1998.
8. Zarkovic K, Zarkovic N, Schlag G, Redl H, Waeg G: Histological aspects of sepsis induced brain changes in a baboon model. In: Shock, sepsis and organ failure, 5th Wiggers Bernard Conference 1996, Schlag G, Redl H, Traber DL (Eds), pp 146-162, Springer-Verlag, Heidelberg, 1997.
9. Zarkovic K, Juric G, Waeg G, Kolenc D, Zarkovic N: Immunohistochemical appearance of HNE-protein conjugates in human astrocytomas. BioFactors, 24: 33-40, 2005.
10. Zarkovic K, Uchida K, Kolenc D, Hlupic L, Zarkovic N: Tissue distribution of lipid peroxidation product acrolein in human colon carcinogenesis. Free Radic Res, 40: 543-552, 2006.
11. Zarkovic N, Schaur RJ, Puhl R, Jurin M, Esterbauer H: Mutual dependence of growth modifying effects of 4-hydroxynonenal and fetal calf serum in vitro. Free Radic Biol Med, 16: 877-884, 1994.
12. Esterbauer H, Schaur RJ, Zollner H: Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Rad Biol Med, 11: 81-128, 1991.
13. Zarkovic N: Mechanismus der Tumorentstehung. Pharmazeutische Zeitung, 145: 239-245, 2000.
14. Mertscha K, Blasigb I, Grune T: 4-Hydroxynonenal impairs the permeability of an in vitro rat blood-brain barrier. Neurosci Lett, 314: 135-138, 2001.
15. Zarkovic K: 4-Hydroxynonenal and neurodegenerative diseases. Mol Asp Med, 24: 293-303, 2003.
16. Barnham KJ, Masters CL, Bush AI: Neurodegenerative diseases and oxidative stress. Nat Rev Drug Discov, 3: 205-214, 2004.
17. Kawaguchi-Niida M, Shibata N, Morikawa S, Uchida K, Yamamoto T, Sawada T, Kobayashi M: Crotonaldehyde accumulates in glial cells of Alzheimer's disease brain. Acta Neuropathol, 111: 422-429, 2006.
18. Cirak B, Inci S, Palaoglu S, Bertan V: Lipid peroxidation in cerebral tumors. Clin Chim Acta, 327: 103-107, 2003.
19. Rao GM, Rao AV, Raja A, Rao S, Rao A: Role of antioxidant enzymes in brain tumours. Clin Chim Acta, 296: 203-212, 2000.
20. Wozniak B, Wozniak A, Kasprzak HA, Drewa G, Mila-Kierzenkowska C, Drewa T, Planutis G: Lipid peroxidation and activity of some antioxidant enzymes in patients with glioblastoma and astrocytomas. J Neurooncol, 81: 21-26, 2007.
21. Zajdel A, Wilczok A, Slowinski J, Orchel J, Mazurek U: Aldechydic lipid peroxidation products in human brain astrocytomas. J Neurooncol, 84: 167-173, 2007.
22. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (Eds): WHO classification of tumours of the central nervous system. IARC, Lyon, 2007.
23. Waeg G, Dimsity G, Esterbauer H: Monoclonal antibodies for detection of 4-hydroxynonenal modified proteins. Free Radic Res, 25: 149-159, 1996.
24. Juric G, Zarkovic N, Nola M, Jukic S, Tillian M: The value of cell proliferation and angiogenesis in the prognostic assessment of ovarian granulosa cell tumors. Tumori, 87: 47-53, 2001.
25. Schlag G, Zarkovic K, Redl H, Zarkovic N, Waeg G: Brain damage secondary to hemorrhagic shock in baboons. In: Shock, Sepsis and Organ Failure, Schlag G, Redl H, Traber DL (Eds) 5th Wiggers Bernard Conference 1996, pp 3-17, Springer-Verlag, Heidelberg, 1997.
26. Zarkovic N: 4-Hydroxynonenal as a bioactive marker of pathophysiological processes. Mol Aspects Med, 24: 293-303, 2003.
27. Uchida K: 4-Hydroxy-2-nonenal: a product and mediator of oxidative stress. Prog Lipid Res, 42: 318-343, 2003.
28. Satoh J, Tabunoki H, Nanri Y, Arima K, Yamamura T: Human astrocytes express 14-3-3 sigma in response to oxidative and DNA-damaging stresses. Neurosci Res 56: 61-72, 2006.
29. Toyokuni S, Okamoto K, Yodoi J, Hiai H: Persistent oxidative stress in cancer. FEBS Lett, 358: 1-3, 1995.
30. Halliwell B: Oxidative stress and cancer: have we moved forward? Biochem J, 401: 1-11, 2007.
31. Brown NS, Bicknell R: Hypoxia and oxidative stress in breast cancer: Oxidative stress - its effects on the growth, metastatic potential and response to therapy of breast cancer. Breast Cancer Res, 3: 323-327, 2001.
32. Zaidi SM, Banu N: Antioxidant potential of vitamins A, E and C in modulating oxidative stress in rat brain. Clin Chim Acta, 340: 229-233, 2004.
33. Zarkovic N, Zarkovic K, Schaur RJ, Stolc S, Schlag G, Redl H, Waeg G, Borovic S, Loncaric I, Juric G, Hlavka V: 4-Hydroxynonenal as a second messenger of free radicals and growth modifying factor. Life Sci, 65: 1901-1904, 1999.
34. Kumagai T, Nakamura Y, Osawa T, Uchida K: Role of p38 mitogen-activated protein kinase in the 4-hydroxy-2-nonenal-induced cyclooxygenase-2 expression. Arch Biochem Biophys, 397: 240-245, 2002.
35. Kruman I, Bruce-Keller AJ, Bredesen D, Waeg G, Mattson MP: Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis. J Neurosci, 17: 5089-5100, 1997.
36. Mattson MP, Haddon RC, Rao AM: Molecular functionalization of carbon nanotubes and use as substrates for neuronal growth. J Mol Neurosci, 14: 175-182, 2000.
37. Zarkovic N, Ilic Z, Jurin M, Schaur RJ, Puhl H, Esterbauer H: Stimulation of HeLa cell growth by physiological concentrations of 4-hydroxynonenal. Cell Biochem Funct, 11: 279-286, 1993.
38. Bonfoco E, Krainc D, Ankarcrona M, Nicotera P, Lipton SA: Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc Natl Acad Sci USA, 92: 7162-7166, 1995.
39. Awasthi YC, Sharma R, Cheng JZ, Yang Y, Sharma A, Singhal SS, Awasthi S: Role of 4-hydroxynonenal in stress-mediated apoptosis signaling. Mol Aspects Med, 24: 219-230, 2003.
40. Sastre J, Pallardo FV, Vina J: Glutathione, oxidative stress and aging. Age, 19: 129-139, 1996.
41. Ayalasomayajula SP, Kompell UB: Induction of vascular endothelial growth factor by 4-hydroxynonenal and its prevention by glutathione precursors in retinal pigment epithelial cells. Eur J Pharmacol, 449: 213-220, 2002.
42. Hovinga KE, Stalpers LJ, van Bree C, Donker M, Verhoeff JJ, Rodermond HM, Bosch DA, van Furth WR: Radiation-enhanced vascular endothelial growth factor (VEGF) secretion in glioblastoma multiforme cell lines - a clue to radioresistance? J Neurooncol, 74: 99-103, 2005.
43. Gupta K, Radotra BD, Banarjee AK, Nijhawan R: Quantitation of angiogenesis and its correlation with vascular endothelial growth factor expression in astrocytic tumors. Anal Quant Cytol Histol, 26: 223-229, 2004.